139 related articles for article (PubMed ID: 27624865)
21. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
[TBL] [Abstract][Full Text] [Related]
22. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
23. Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma.
Sorbello V; Ciprandi G; Di Stefano A; Massaglia GM; Favatà G; Conticello S; Malerba M; Folkerts G; Profita M; Rolla G; Ricciardolo FL
Allergy; 2015 Feb; 70(2):236-40. PubMed ID: 25394579
[TBL] [Abstract][Full Text] [Related]
24. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
[TBL] [Abstract][Full Text] [Related]
25. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma.
Takhar P; Corrigan CJ; Smurthwaite L; O'Connor BJ; Durham SR; Lee TH; Gould HJ
J Allergy Clin Immunol; 2007 Jan; 119(1):213-8. PubMed ID: 17208604
[TBL] [Abstract][Full Text] [Related]
26. Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
Zhou Y; Ren J; Li P; Ma R; Zhou M; Zhang N; Kong X; Hu Z; Xiao X
Arch Med Res; 2019 Jul; 50(5):249-256. PubMed ID: 31593848
[TBL] [Abstract][Full Text] [Related]
27. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
28. Mast Cell Proteases Promote Diverse Effects on the Plasminogen Activation System and Wound Healing in A549 Alveolar Epithelial Cells.
Mogren S; Berlin F; Eskilsson L; Van Der Burg N; Tufvesson E; Andersson CK
Cells; 2022 Sep; 11(18):. PubMed ID: 36139491
[TBL] [Abstract][Full Text] [Related]
29. Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.
Brooks AM; Bates ME; Vrtis RF; Jarjour NN; Bertics PJ; Sedgwick JB
Am J Respir Cell Mol Biol; 2006 Oct; 35(4):503-11. PubMed ID: 16728704
[TBL] [Abstract][Full Text] [Related]
30. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group.
Amin K; Lúdvíksdóttir D; Janson C; Nettelbladt O; Björnsson E; Roomans GM; Boman G; Sevéus L; Venge P
Am J Respir Crit Care Med; 2000 Dec; 162(6):2295-301. PubMed ID: 11112154
[TBL] [Abstract][Full Text] [Related]
31. Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China.
Qin DD; Song D; Huang J; Yu F; Zhao MH
Lupus; 2015 May; 24(6):546-57. PubMed ID: 25411257
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients.
Grunnet M; Christensen IJ; Lassen U; Jensen LH; Lydolph M; Lund IK; Thurison T; Høyer-Hansen G; Mau-Sørensen M
Clin Biochem; 2014 May; 47(7-8):599-604. PubMed ID: 24530340
[TBL] [Abstract][Full Text] [Related]
33. Association between promoter region of the uPAR (rs344781) gene polymorphism in genetic susceptibility to migraine without aura in three Iranian hospitals.
Zandifar A; Soleimani S; Iraji N; Haghdoost F; Tajaddini M; Javanmard SH
Clin Neurol Neurosurg; 2014 May; 120():45-8. PubMed ID: 24731575
[TBL] [Abstract][Full Text] [Related]
34. Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection.
Roelofs JJ; Rowshani AT; van den Berg JG; Claessen N; Aten J; ten Berge IJ; Weening JJ; Florquin S
Kidney Int; 2003 Nov; 64(5):1845-53. PubMed ID: 14531820
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.
Koch A; Zimmermann HW; Gassler N; Jochum C; Weiskirchen R; Bruensing J; Buendgens L; Dückers H; Bruns T; Gerken G; Neumann UP; Adams DH; Trautwein C; Canbay A; Tacke F
Liver Int; 2014 Oct; 34(9):1330-9. PubMed ID: 24575897
[TBL] [Abstract][Full Text] [Related]
36. Bradykinin B2 receptor expression in the bronchial mucosa of allergic asthmatics: the role of NF-kB.
Ricciardolo FL; Petecchia L; Sorbello V; Di Stefano A; Usai C; Massaglia GM; Gnemmi I; Mognetti B; Hiemstra PS; Sterk PJ; Sabatini F
Clin Exp Allergy; 2016 Mar; 46(3):428-38. PubMed ID: 26588817
[TBL] [Abstract][Full Text] [Related]
37. Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance.
Andres SA; Edwards AB; Wittliff JL
J Clin Lab Anal; 2012 Feb; 26(2):93-103. PubMed ID: 22467324
[TBL] [Abstract][Full Text] [Related]
38. Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma.
Turato G; Barbato A; Baraldo S; Zanin ME; Bazzan E; Lokar-Oliani K; Calabrese F; Panizzolo C; Snijders D; Maestrelli P; Zuin R; Fabbri LM; Saetta M
Am J Respir Crit Care Med; 2008 Sep; 178(5):476-82. PubMed ID: 18511700
[TBL] [Abstract][Full Text] [Related]
39. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
[TBL] [Abstract][Full Text] [Related]
40. In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.
Ulisse S; Baldini E; Sorrenti S; Barollo S; Prinzi N; Catania A; Nesca A; Gnessi L; Pelizzo MR; Mian C; De Vito C; Calvanese A; Palermo S; Persechino S; De Antoni E; D'Armiento M
Clin Endocrinol (Oxf); 2012 Nov; 77(5):780-6. PubMed ID: 22702340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
